Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression

By Grillo Mary   Bott Matthew   Khandke Neha   McGinnis John   Miranda Miriam   Meyyappan Muthupalaniappan   Rosfjord Edward   Rabindran Sridhar  

Breast Cancer Research and Treatment, Vol. 95, Iss. 2, 2006-01 ,pp. : 185-194

Springer Publishing Company

Access to resources Recommend Favorite

Examining the role of cyclin D1 in breast cancer

By Velasco-Veláázquez Marco A   Li Zhiping   Casimiro Mathew   Loro Emanuele   Homsi Nora   Pestell Richard G  

Future Oncology, Vol. 7, Iss. 6, 2011-06 ,pp. : 753-765

Future Medicine

Access to resources Recommend Favorite

Cyclin D1, EMS1 and 11q13 Amplification in Breast Cancer

By Ormandy C.J.   Musgrove E.A.   Hui R.   Daly R.J.   Sutherland R.L.  

Breast Cancer Research and Treatment, Vol. 78, Iss. 3, 2003-04 ,pp. : 323-335

Springer Publishing Company

Access to resources Recommend Favorite

Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil

By            

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 2007-2014

Spandidos Publications

Access to resources Recommend Favorite

Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance

By Ahnström Marie  

Breast Cancer Research and Treatment, Vol. 91, Iss. 2, 2005-05 ,pp. : 145-151

Springer Publishing Company

Access to resources Recommend Favorite